Considering most medicines cost the drug manufacturers pennies to produce, that seems fair. The US association PhRMA was my client and we had to push the BS narrative about "recovering the cost of development" to the media all the time but the truth is, they spend far more on advertising than they do on R&D. Pharmaceutical people wade in money bigger than kings.
Ann: Pause in Trade, page-24
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7008 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 9498 | 1 |
View Market Depth
| Last trade - 09.55am 20/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
Day chart unavailable